Home | Depressive Disorders | What Is Treatment-Resistant Depression?

What Is Treatment-Resistant Depression?

An adult stands in warm golden light, looking upward with a calm, hopeful expression
Table of Contents

Treatment-resistant depression (TRD) is major depressive disorder that has not improved after at least two adequate trials of antidepressant medication from different classes, each taken at the right dose for the right length of time. The word adequate is key, because many cases labeled resistant were never fully treated.

A diagnosis of TRD is not a dead end. It is usually a signal to reassess the diagnosis and the treatment plan rather than to give up on recovery from major depression. This guide explains what TRD is, why it happens, and how it is treated.

At our Roseville facility, our clinical team treats adults 18 and older across Greater Sacramento and Placer County whose depression has not responded to outpatient treatment and needs a more structured approach.

Key Takeaways

  • TRD has a specific definition: depression that persists after two or more adequate antidepressant trials.
  • Adequate is the key word: the right drug, the right dose, and enough time, often missing in real-world care.
  • It is often a clue, not a verdict: an undiagnosed condition such as bipolar disorder may be the real issue.
  • A fresh assessment comes first: rule out misdiagnosis, co-occurring conditions, and medical causes.
  • Treatment goes beyond more pills: optimizing medication, structured therapy, and intensive care all help.
  • Residential care reassesses and resets when outpatient treatment has stalled.
Speak with admissions about a fresh assessment
No pressure, no commitment.
📞 (916) 527-9606

What Treatment-Resistant Depression Is

1 in 3
adults with major depression do not fully respond to initial antidepressant treatment
Source: StatPearls (NCBI)

TRD is defined by a lack of response to adequate treatment, not simply by how long someone has felt depressed. The bar for adequate is specific, and it is often where real-world treatment falls short.

The table below shows what makes an antidepressant trial adequate. A trial that misses any of these is not a true test of the medication.

FactorWhat Adequate Means
Right medicationAn antidepressant proven for major depression
Right doseA therapeutic dose, not a sub-therapeutic one
Enough timeTypically six to eight weeks at that dose
ConsistencyTaken as prescribed, without long gaps
Different classesAt least two trials from different drug classes

According to the National Institute of Mental Health, depression is highly treatable, and when first treatments do not work, other approaches often do. TRD is a reason to look deeper, not to stop.

"

A diagnosis of treatment-resistant depression is usually a signal to reassess, not a reason to give up on recovery.

— Dr. Bonnie J. Mitchell, DBH, LPCC, Clinical Director

Why Depression Becomes Treatment-Resistant

One of the most common reasons is misdiagnosis. Depression that does not respond to antidepressants is sometimes bipolar disorder, which needs mood stabilization rather than antidepressants alone.

Other reasons include co-occurring conditions that go untreated. Unaddressed anxiety or co-occurring substance use can keep depression locked in place no matter how many antidepressants are tried.

Clinical references including StatPearls note that medical conditions, inconsistent treatment, and inadequate dosing all contribute to apparent resistance.

The table below summarizes the most common reasons depression looks resistant when it may not truly be.

ReasonWhat It Means
MisdiagnosisThe depression is part of bipolar disorder or another condition
Under-treatmentThe dose was too low or the trial too short to work
Co-occurring conditionsUntreated anxiety or substance use keeps depression in place
Inconsistent useMedication was missed often enough to blunt its effect
Medical causesThyroid or other medical issues mimic or worsen depression

Why a Fresh Comprehensive Assessment Matters

Because so much TRD is really a missed diagnosis or an under-treated condition, a thorough reassessment is the first step. Our comprehensive assessment screens for bipolar disorder, co-occurring conditions, and medical causes before changing the plan.

Getting the diagnosis right is often what unlocks progress. The goal is to treat the real problem, not to keep cycling through medications that were never going to work.

Comprehensive banner

A Fresh Clinical Reassessment

Much treatment-resistant depression is a missed diagnosis. Our comprehensive assessment screens for what earlier care may have overlooked.

About the assessment

How Treatment-Resistant Depression Is Treated

Treatment starts by correcting whatever made the depression look resistant. From there, medication management optimizes dose and choice, and may combine or switch medications based on the reassessment.

Structured psychotherapy is central, because evidence-based talk therapy treats depression that medication alone cannot reach. The intensity of a residential setting lets this happen daily rather than weekly.

A typical stay runs around 30 days, followed by a step-down to outpatient or virtual support at another organization. Additional medical treatments for severe depression exist and are discussed individually as part of care planning.

When Treatment-Resistant Depression Needs Residential Care

!

In Crisis Right Now?

If you or someone you love is in immediate psychiatric crisis, call or text 988 — the Suicide and Crisis Lifeline. Available 24/7, confidential, free.

If life is in danger, call 911. Sacramento Mental Health is a residential treatment program — not an acute crisis or emergency service.

Residential care fits when depression has not responded to outpatient treatment, when safety is a concern, or when a person needs a full reassessment in a structured setting. The change of environment itself can help break a stalled pattern.

We admit adults 18 and older, and adults who need detox first are connected to a partnering provider before admission.

Depression not lifting despite treatment?

Call our admissions team about a clinical assessment, coverage, and what residential care at our Roseville facility would look like for you or your loved one.

24/7 admissions line

Frequently Asked Questions About Treatment-Resistant Depression

What counts as treatment-resistant depression?

TRD is usually defined as major depression that has not improved after at least two adequate antidepressant trials from different classes. Adequate means the right medication, at a therapeutic dose, for long enough, taken consistently. Many cases labeled resistant simply were not fully treated.

Does treatment-resistant depression mean nothing will work?

No. The label describes what has not worked so far, not a permanent state. Many people improve once the diagnosis is reviewed, co-occurring conditions are treated, and the plan is adjusted. It is a reason to look deeper, not to give up.

Could my treatment-resistant depression actually be bipolar disorder?

It is possible and worth checking. Depression that does not respond to antidepressants is sometimes bipolar disorder, which needs mood stabilization rather than antidepressants alone. A careful history of past highs is part of a thorough reassessment.

Why would residential care help when medication has not?

Residential care does more than change medication. It provides a full reassessment, daily structured therapy, and a change of environment that can interrupt a stalled pattern. Treating an overlooked condition is often what finally moves things.

When should treatment-resistant depression be treated in residential care?

Consider it when depression has not responded to outpatient treatment, when safety is a concern, or when a full reassessment in a structured setting is needed. Our Roseville program admits adults 18 and older who need more than weekly outpatient support.

Picture of Clincially Reviewed By Dr. Bonnie J. Mitchell DBH, LPCC

Clincially Reviewed By Dr. Bonnie J. Mitchell DBH, LPCC

Dr. Bonnie Mitchell is a behavioral health leader, clinician, and advocate dedicated to expanding access to compassionate, evidence-based mental health and substance use treatment. She earned her Doctor of Behavioral Health degree from Arizona State University in 2018, holds a Master’s degree in Clinical Counseling for Mental Health, and a Bachelor’s degree in Psychology.

Table of Contents